A detailed history of Hopwood Financial Services, Inc. transactions in Biogen Inc. stock. As of the latest transaction made, Hopwood Financial Services, Inc. holds 300 shares of BIIB stock, worth $42,762. This represents 0.03% of its overall portfolio holdings.

Number of Shares
300
Holding current value
$42,762
% of portfolio
0.03%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 07, 2025

BUY
$146.47 - $191.55 $43,941 - $57,465
300 New
300 $45.9 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $20.5B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Hopwood Financial Services, Inc. Portfolio

Follow Hopwood Financial Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hopwood Financial Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hopwood Financial Services, Inc. with notifications on news.